表紙
市場調查報告書

亞太地區的自我監測血糖儀(SMBG)市場 - 成長,趨勢,預測(2019年∼2024年)

Asia-Pacific Self-monitoring Blood Glucose Devices Market - Growth, Trends, and Forecast (2020 - 2025)

出版商 Mordor Intelligence LLP 商品編碼 808268
出版日期 內容資訊 英文 127 Pages
商品交期: 2-3個工作天內
價格
Back to Top
亞太地區的自我監測血糖儀(SMBG)市場 - 成長,趨勢,預測(2019年∼2024年) Asia-Pacific Self-monitoring Blood Glucose Devices Market - Growth, Trends, and Forecast (2020 - 2025)
出版日期: 2020年02月01日內容資訊: 英文 127 Pages
簡介

亞太地區的自我監測血糖儀(SMBG)依然處於成長階段。中國的自我監測血糖儀市場,預測2019年將達到9億美元規模。由於糖尿病患者數的增加,及診斷及治療藥的持續性創新促進該市場成長。

本報告提供亞太地區的自我監測血糖儀(SMBG)市場調查,市場概要,各各類別的市場規模的變化與預測,市場成長要素及阻礙因素分析,競爭情形,主要企業的簡介等全面性資訊。

目錄

第1章 簡介

  • 調查成果
  • 前提條件
  • 調查範圍

第2章 調查方法

第3章 摘要整理

第4章 市場動態

  • 市場概況
  • 成長要素
  • 阻礙因素
  • 波特的五力分析
    • 買方議價能力
    • 供給企業談判力
    • 新加入業者的威脅
    • 替代品的威脅
    • 競爭企業間的敵對關係

第5章 市場區隔

  • 血糖自我監測測量儀
    • 各零件
      • 血糖儀
      • 測試紙
      • 採血針
    • 各終端用戶
      • 醫院
      • 個人
  • 各地區
    • 亞太地區
      • 日本
      • 韓國
      • 中國
      • 印度
      • 澳洲
      • 越南
      • 馬來西亞
      • 印尼
      • 菲律賓
      • 泰國
      • 其他

第6章 市場指標

  • 第一型糖尿病人口(實在數值、預測值)
  • 第二型糖尿病人口(實在數值、預測值)

第7章 競爭情形

  • 企業簡介
    • Abbott Diabetes Care
    • Roche
    • Johnson & Johnson
    • Arkray
    • Ascensia Diabetes Care
    • Agamatrix Inc.
    • Bionime Corporation
    • Acon
    • Medisana
    • Trivida
    • I-Sens
    • Morpen Laboratories
    • Rossmax
  • 企業佔有率分析
    • Roche
    • Johnson & Johnson
    • Abbott Diabetes Care
    • 其他

第8章 市場機會及市場趨勢

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 65537

Market Overview

The Asia-Pacific self-monitoring blood glucose devices market is segmented into blood glucose meters, blood glucose testing strips, and lancets. Self-monitoring blood glucose (SMBG) devices markets across the Asia Pacific are still in their growing phases. In China, the market size for self-monitoring blood glucose devices is projected to reach USD 0.9 billion by 2019. The market is driven by the increasing diabetic population and continuous innovations in the diagnosis and treatment of diabetes. The Chinese and Japanese markets are the most competitive ones, with a significant number of market players and strong local competition.

Asia-Pacific is at the fore front of the diabetic epidemic, with more than 200 million people suffering from diabetes in 2013, and this number is expected to increase in the coming years. 6.3% of the total APAC population was suffering from diabetes in 2015. With the increasing rate of diabetes cases, self-monitoring with glucose meters and strips has become an important aspect of diabetes care and management.

Scope of the Report

This report includes a detailed study about self-monitoring blood glucose devices, test strips and lancets in the Asia-Pacific market, and further study includes hospital usage and home usage of glucometer devices, test strips, and lancets, in each country.

Key Market Trends - In Asia-Pacific, Glucometer Device Segment Registered the Highest CAGR with 10.6%

The personal-use glucometer is expected to see high sales in the future, owing to the rising awareness and reducing costs associated with the glucometer.

Glucometers, which can be used for critically ill patients, have been approved, like the finger stick glucometer that is available in the market.

The glucometer segment is expected to continue to expand in the future, due to the innovative developments in the same, such as glucometers that can be plugged into smartphones using headphone jack, to automatically record the values. Additionally, making the devices light with long efficient batteries would further promote the adoption of glucometer.

China has the Highest Market Share in Asia-Pacific and Will Continue to Grow in the Future with the CAGR of 7.63%

China faces the largest diabetes epidemic in the world. The number of insulin users increased among the Chinese population, with an increase in Type 1 and Type 2 patients. The trend of self-monitoring blood glucose levels increased more among the Type 1 population. The Chinese blood glucose monitoring market has majorly increased to monitor glycosylated haemoglobin (HbA1c) levels.

In 2015, in the Chinese blood glucose monitoring devices market, the consumables accounted for 88.6%, of which, 75.88% of the market share was held by test strips and the 11.2% was occupied by glucometer devices.

Competitive Landscape

The Asia-Pacific self-monitoring blood glucose devices market is highly fragmented with few major manufacturers gaining presence in major countries of the Asia-Pacific market, while the remaining market comprises other local or region-specific manufacturers.

Mergers and acquisitions that happened between players in the recent past helped the companies to strengthen their market presence; for instance, Ascensia Diabetes Care was established itself in 2016 through the acquisition of Bayer Diabetes Care by PHC Holdings (formerly known as Panasonic Healthcare Holdings).

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Drivers
  • 4.3 Restraints
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Bargaining Power of Suppliers
    • 4.4.2 Bargaining Power of Consumers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Threat of Substitute Products and Services
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 Self -monitoring Blood Glucose Devices
    • 5.1.1 By Component (Market Size, Value and Volume)
      • 5.1.1.1 Glucometer Devices
      • 5.1.1.2 Test Strips
      • 5.1.1.3 Lancets
    • 5.1.2 By End User
      • 5.1.2.1 Hospital (Market Size, Value and Volume)
      • 5.1.2.1.1 Glucometer Devices
      • 5.1.2.1.2 Test Strips
      • 5.1.2.1.3 Lancets
      • 5.1.2.2 Personal (Market Size, Value and Volume)
      • 5.1.2.2.1 Glucometer Devices
      • 5.1.2.2.2 Test Strips
      • 5.1.2.2.3 Lancets
  • 5.2 By Geography
    • 5.2.1 Asia-Pacific
      • 5.2.1.1 Japan (Market Size, Value and Volume)
      • 5.2.1.1.1 By Component (Glucometer Device, Test Strips, Lancets)
      • 5.2.1.1.2 By End User (Hospital and Home)
      • 5.2.1.1.3 By Company (Roche, Abbott, Johnson & Johnson, and Others)
      • 5.2.1.2 South Korea (Market Size, Value and Volume)
      • 5.2.1.2.1 By Component (Glucometer Device, Test Strips, Lancets)
      • 5.2.1.2.2 By End User (Hospital and Home)
      • 5.2.1.2.3 By Company (Roche, Abbott, Johnson & Johnson, and Others)
      • 5.2.1.3 China (Market Size, Value and Volume)
      • 5.2.1.3.1 By Component (Glucometer Device, Test Strips, Lancets)
      • 5.2.1.3.2 By End User (Hospital and Home)
      • 5.2.1.3.3 By Company (Roche, Abbott, Johnson & Johnson, and Others)
      • 5.2.1.4 India (Market Size, Value and Volume)
      • 5.2.1.4.1 By Component (Glucometer Device, Test Strips, Lancets)
      • 5.2.1.4.2 By End User (Hospital and Home)
      • 5.2.1.4.3 By Company (Roche, Abbott, Johnson & Johnson, and Others)
      • 5.2.1.5 Australia (Market Size, Value and Volume)
      • 5.2.1.5.1 By Component (Glucometer Device, Test Strips, Lancets)
      • 5.2.1.5.2 By End User (Hospital and Home)
      • 5.2.1.5.3 By Company (Roche, Abbott, Johnson & Johnson, and Others)
      • 5.2.1.6 Vietnam (Market Size, Value and Volume)
      • 5.2.1.6.1 By Component (Glucometer Device, Test Strips, Lancets)
      • 5.2.1.6.2 By End User (Hospital and Home)
      • 5.2.1.6.3 By Company (Roche, Abbott, Johnson & Johnson, and Others)
      • 5.2.1.7 Malaysia (Market Size, Value and Volume)
      • 5.2.1.7.1 By Component (Glucometer Device, Test Strips, Lancets)
      • 5.2.1.7.2 By End User (Hospital and Home)
      • 5.2.1.7.3 By Company (Roche, Abbott, Johnson & Johnson, and Others)
      • 5.2.1.8 Indonesia (Market Size, Value and Volume)
      • 5.2.1.8.1 By Component (Glucometer Device, Test Strips, Lancets)
      • 5.2.1.8.2 By End User (Hospital and Home)
      • 5.2.1.8.3 By Company (Roche, Abbott, Johnson & Johnson, and Others)
      • 5.2.1.9 Philippines (Market Size, Value and Volume)
      • 5.2.1.9.1 By Component (Glucometer Device, Test Strips, Lancets)
      • 5.2.1.9.2 By End User (Hospital and Home)
      • 5.2.1.9.3 By Company (Roche, Abbott, Johnson & Johnson, and Others)
      • 5.2.1.10 Thailand (Market Size, Value and Volume)
      • 5.2.1.10.1 By Component (Glucometer Device, Test Strips, Lancets)
      • 5.2.1.10.2 By End User (Hospital and Home)
      • 5.2.1.10.3 By Company (Roche, Abbott, Johnson & Johnson, and Others)
      • 5.2.1.11 Rest of Asia-Pacific (Market Size, Value and Volume)
      • 5.2.1.11.1 By Component (Glucometer Device, Test Strips, Lancets)
      • 5.2.1.11.2 By End User (Hospital and Home)
      • 5.2.1.11.3 By Company (Roche, Abbott, Johnson & Johnson, and Others)

6 MARKET INDICATORS

  • 6.1 Type 1 Diabetes Population (2012-2024)
  • 6.2 Type 2 Diabetes Population (2012-2024)

7 COMPETITIVE LANDSCAPE

  • 7.1 COMPANY PROFILES
    • 7.1.1 Abbott Diabetes Care
    • 7.1.2 Roche
    • 7.1.3 Johnson & Johnson
    • 7.1.4 Arkray
    • 7.1.5 Ascensia Diabetes Care
    • 7.1.6 Agamatrix Inc.
    • 7.1.7 Bionime Corporation
    • 7.1.8 Acon
    • 7.1.9 Medisana
    • 7.1.10 Trivida
    • 7.1.11 I-Sens
    • 7.1.12 Morpen Laboratories
    • 7.1.13 Rossmax
  • 7.2 COMPANY SHARE ANALYSIS
    • 7.2.1 Roche
    • 7.2.2 Johnson & Johnson
    • 7.2.3 Abbott Diabetes Care
    • 7.2.4 Others

8 MARKET OPPORTUNITIES AND FUTURE TRENDS

Back to Top